16 November 2021 in Journal of Breath Research
Introduction . Exhaled breath acetone (ExA) has been investigated as a biomarker for heart failure (HF). Yet, barriers to its use in the clinical field have not been identified. The aim of this systematic review and meta-analysis was to assess the ExA heterogeneity and factors of variability in healthy controls (HC), to identify its relations with HF diagnosis and prognostic factors and to assess its diagnosis and prognosis accuracy in HF patients. Methods . A systematic search was conducted in PUBMED and Web of Science database. All studies with HC and HF patients with a measured ExA were included and studies providing ExA’s diagnosis and prognosis accuracy were identified. Results . Out of 971 identified studies, 18 studies involving 833 HC and 1009 HF patients were included in the meta-analysis. In HC, ExA showed an important heterogeneity ( I 2 = 99%). Variability factors were fasting state, sampling type and analytical method. The mean ExA was 1.89 times higher in HF patients vs. HC (782 [531–1032] vs. 413 [347–478] ppbv; p < 0.001). One study showed excellent diagnosis accuracy, and one showed a good prognosis value. ExA correlated with New York Heart Association (NYHA) dyspnea ( p < 0.001) and plasma brain natriuretic peptide ( p < 0.001). Studies showed a poor definition and reporting of included subjects. Discussion . Despite the between-study heterogeneity in HC, the evidence of an excellent diagnosis and prognosis value of ExA in HF from single studies can be extended to clinical populations worldwide. Factors of variability (ExA procedure and breath sampling) could further improve the diagnosis and prognosis values of this biomarker in HF patients.
1 January 2021 in Progress in Biophysics and Molecular Biology
29 September 2022 in Archives of Cardiovascular Diseases
12 August 2025 in Clinical Journal of the American Society of Nephrology
Key Points: Physical exercise before hemodialysis is as cardioprotective as intradialytic exercise. Predialytic exercise potentially addresses several modality-specific barriers and challenges encountered by both health care providers and patients. These are likely mediated by mechanisms inherent to exercise itself, rather than by transient central and/or systemic hemodynamic alterations. Background: Hemodialysis induces left ventricular regional wall motion abnormalities (RWMAs) due to myocardial hypoperfusion. Although acute intradialytic exercise (IDE) has shown cardioprotective effects, its routine implementation faces feasibility challenges, and the potential of predialysis exercise as an alternative remains unexplored. This study aimed to compare the effect of predialysis exercise and IDE on hemodialysis-induced myocardial stunning. Methods: In this open-label, randomized cross-over trial, 25 patients with ESKD underwent to each of three hemodialysis conditions, administrated in random order: standard hemodialysis (HD-CONT), hemodialysis with IDE (HD-PER), and hemodialysis preceded by exercise (HD-PRE). Two-dimensional echocardiography and whole blood viscosity (WBV) measurements were performed both immediately before hemodialysis onset (T0) and at peak stress of hemodialysis (Tpeak). Left ventricular longitudinal strain from an 18-segment model was used to assess the presence of RWMAs. Regular monitoring of cardiovascular hemodynamics was set up with measurements staggered every 30 minutes. Results: Compared with HD-CONT, there was a significant reduction in RWMAs during both HD-PER (estimated difference, 1.60 segments; 95% confidence interval, 0.09 to 3.10; P = 0.04) and HD-PRE (estimated difference, 1.72 segments; 95% confidence interval, 0.21 to 3.22; P = 0.02). The magnitude of the exercise-induced reduction in myocardial stunning did not differ between HD-PER and HD-PRE (P = 0.86). Apart from the exercise period itself, kinetics of all hemodynamic variables were similar between HD-CONT and HD-PER, whereas they were totally similar between HD-CONT and HD-PRE. No associations of changes in RWMAs and hemodynamics variables between HD-CONT versus HD-PRE or HD-PER were found (P > 0.42). Comparing HD-CONT versus HD-PER, WBV was preserved in HD-PER and changes in RWMAs were associated with changes in WBV at high shear rates (225 s−1: P = 0.006; 90 s−1: P = 0.04). Conclusions: Physical exercise performed before hemodialysis provides cardioprotective effects comparable with those of IDE. The mechanisms behind these benefits do not seem to involve hemodynamic factors. Clinical Trial registry name and registration number: NCT04831021.
16 October 2024 in Sports Medicine
Introduction: Prolonged strenuous exercise can transiently decrease cardiac function. Other studies have identified three major exercise-induced pulmonary changes: bronchoconstriction, dynamic hyperinflation and pulmonary oedema with reduced alveolar–capillary membrane diffusing capacity. This study investigated whether athletes with one of these pulmonary dysfunctions following a very long-distance triathlon exhibit similar cardiac alterations as those without dysfunctions. Methods: Sixty trained male triathletes (age 39 ± 9 years) underwent baseline and post-race assessments, including echocardiography (with standard, 2D-strain and myocardial work assessments), spirometry and double-diffusion technique to evaluate alveolar–capillary membrane diffusing capacity for carbon monoxide (DM CO ). Cardiac function in athletes with exercise-induced bronchoconstriction (> 10% decrease FEV 1 ), dynamic hyperinflation (> 10% decrease inspiratory capacity) or impaired diffusion capacity (> 20% decrease DM CO /alveolar volume) were compared with those without these dysfunctions. Results: The race lasted 14 h 20 min ± 1 h 26 min. Both systolic and diastolic cardiac functions declined post-race. Post-race, 18% of athletes had bronchoconstriction, 58% dynamic hyperinflation and 40% impaired diffusing capacity. Right and left ventricular standard and 2D-strain parameters were similar before the race in all subgroups and changed similarly post-race, except E/E′, which decreased in the bronchoconstriction subgroup and increased in those with diffusion impairment. Global constructive work decreased by ~ 19% post-race (2302 ± 226 versus 1869 ± 328 mmHg%, P < 0.001), more pronounced in athletes with diffusion impairment compared with others (− 26 ± 13 versus − 15 ± 9%, P = 0.001) and positively correlated with DM CO /alveolar volume reduction. Conclusion: After a very long-distance triathlon, bronchoconstriction and hyperinflation were not associated with significant cardiac changes, whereas impaired alveolar–capillary membrane diffusing capacity was associated with a more significant decline in myocardial function. These findings highlight the complex relationship between pulmonary gas exchange abnormalities and cardiac fatigue following prolonged strenuous exercise.
26 December 2025 in Scandinavian Journal of Medicine & Science in Sports
The benefits of regular physical activity are well demonstrated in secondary cardiovascular prevention, but data on high‐intensity exercise after percutaneous coronary intervention (PCI) remain limited. This study aimed to assess whether resuming high‐intensity exercise within the first year after PCI was associated with an increased risk of cardiovascular (CV) events. We prospectively followed 1154 patients who had undergone PCI without prior revascularization. All patients engaged in regular exercise prior to PCI. We compared the 1‐year outcome of patients who resumed high‐intensity exercise with the remaining patients. Within the first year 91.6% of patients resumed exercise (18.0% high‐intensity, 41.0% moderate‐intensity, 32.6% light‐intensity), predominantly endurance‐based (93.3%). No CV death was reported, atrial fibrillation occurred in 27 patients (2.3%), ischemic stroke in 4 (0.3%), ventricular arrhythmias in 9 (0.8%), acute heart failure in 8 (0.7%), and new coronary event in 30 (2.6%); including 21 new stenoses, 4 in‐stent restenoses, and 5 stent thromboses. Four patients experienced an acute coronary syndrome, including 2 during exercise. The 205 patients in the high‐intensity exercise group reported a higher training load (7.0 [5.0–8.0] hours/week vs. 4.0 [2.0–6.0], p < 0.0001). The incidence of CV events did not differ significantly between the groups (total CV events: 5.9% vs. 7.0%, p = 0.541; new coronary events: 1.5% vs. 2.9%, p = 0.250 respectively in the high‐intensity exercise group vs. the remaining patients). These findings indicate no observed increase in short‐term CV events among previously active patients resuming high‐intensity exercise after PCI, but further studies are required to determine whether these observations are generalisable.